Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.75 GBX
Market Closed
Updated:
Apr 20, 2024
Fusion Antibodies PLC
Net Income (Common)
Last
Value
3-Years CAGR
5-Years CAGR
|
Fusion Antibodies PLC
Net Income (Common) Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Net Income (Common)
£-2.8m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Net Income (Common)
£-154.5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Net Income (Common)
£-776k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Net Income (Common)
£724k
|
CAGR 3-Years
22%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Net Income (Common)
£15m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Net Income (Common)
£16.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Net Income (Common)?
Net Income (Common)
-2.8m
GBP
-2.8m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Net Income (Common) amounts to -2.8m GBP.
What is Fusion Antibodies PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-17%
-17%
Over the last year, the Net Income (Common) growth was -64%. The average annual Net Income (Common) growth rates for Fusion Antibodies PLC have been -60% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
